Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer’s disease-associated biomarkers alterations among de novo Parkinson’s disease patients: a prospective cohort study

BACKGROUND: Dementia is a prevalent non-motor manifestation among individuals with advanced Parkinson’s disease (PD). Glial fibrillary acidic protein (GFAP) is an inflammatory marker derived from astrocytes. Research has demonstrated the potential of plasma GFAP to forecast the progression to dement...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tingting, Zuo, Hongzhou, Ma, Di, Song, Dan, Zhao, Yuying, Cheng, Oumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357612/
https://www.ncbi.nlm.nih.gov/pubmed/37475029
http://dx.doi.org/10.1186/s12974-023-02843-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357612/
https://www.ncbi.nlm.nih.gov/pubmed/37475029
http://dx.doi.org/10.1186/s12974-023-02843-5

Ejemplares similares